Drug details

Synagis (palivizumab)

type of RSV Agents

Synagis (palivizumab) is a man-made antibody to respiratory syncytial virus (RSV) used to prevent serious lung disease caused by RSV in premature infants, and infants born with certain lung disorders or heart disease. Synagis will not treat a child who is already sick with RSV disease.

This drug may have the following side effects:

• hives,
• difficulty breathing,
• swelling of your face, lips, tongue, or throat,
• itching,
• muscle weakness, and
• severe rash,
• rapid or difficult breathing,
• blue-colored lips, skin, or fingernails,
• being hard to wake up

The following drugs are related to Synagis, either as a replacement or used together:

• Tylenol (acetaminophen)
• Copegus (ribavirin)
• Rebetol (ribavirin)
• Virazole (ribavirin)